Merck to Buy Idenix Pharma for $3.85 Billion

Merck & Co says the Cambridge, Massachusetts, company has built a promising portfolio of hepatitis C treatments, including three in clinical testing

















from NDTV News - Profit http://ift.tt/1qi822Y